Please use this identifier to cite or link to this item:

Multi-center sestamibi parathyroid imaging study in Hawaii.

File SizeFormat 
1997-05p114-120.pdf548.48 kBAdobe PDFView/Open

Item Summary

Title: Multi-center sestamibi parathyroid imaging study in Hawaii.
Authors: Cheung, Alan H. S.
Wheeler, M S
Madanay, L D
Hew, E
Coel, M N
show 1 moreWong, Livingston M. L.
show less
Issue Date: May 1997
Abstract: Technetium-99m (99mTc) sestamibi (MIBI) was first used as a parathyroid imaging agent in Hawaii in 1991. The purpose of this study was to determine the sensitivity and positive predictive value of the MIBI scan in detecting abnormal parathyroid glands. A retrospective, multi-center study from 1992-1994 involving 33 patients in four hospitals showed the overall sensitivity of the MIBI scan for detecting hyperparathyroid disease was 90%. The positive predictive value was 93%. It was more sensitive in detecting adenomas (95%) than hyperplasia (45%). In conclusion, the MIBI scan can be helpful in detecting abnormal parathyroid glands and may be most useful prior to reoperations for persistent and recurrent hyperparathyroidism.
ISSN: 0017-8594
Appears in Collections:Hawaii Medical Journal Articles For 1997

Items in eVols are protected by copyright, with all rights reserved, unless otherwise indicated.